Remedy Meds vs Ro
Ro costs $150 less a month.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Ro
Best for: knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC
Visit Ro →If you are choosing between Remedy Meds and Ro, the first difference is cost: Ro is $150 a month cheaper at the entry price. Ro leads our six-part score, 6.7 to 5.1. One of the two has an FDA warning letter on record, covered below.
Remedy Meds vs Ro price
Ro is the cheaper way in: $149 a month against $299 a month at Remedy Meds. That is $150 less each month (50% lower), or about $1,800 over a year of treatment.
Medications and formats
Remedy Meds and Ro do not overlap on medication; only Remedy Meds lists semaglutide and tirzepatide; only Ro lists orforglipron.
On format, Remedy Meds prices compounded injections, while Ro prices brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Ro is the only one of the two with a brand-name price.
Where each one treats patients
Neither Remedy Meds nor Ro publishes the states it serves, so enter your state at the very start of each sign-up.
Pricing
Remedy Meds
Ro
Additional membership fees apply
What each price covers
Both prices cover the clinician visit.
Remedy Meds' price also covers the medication itself and shipping, which Ro does not claim.
Ro's price also covers lab work and coaching, which Remedy Meds does not claim.
Remedy Meds is silent on lab work and coaching.
Ro is silent on shipping.
That matters most for the drug: unless Ro confirms otherwise, budget for medication on top of its listed price.
Remedy Meds
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Ro
Covered by the monthly price
Medication
Charged on top
Clinician visits
In the price
Shipping
Not stated
Lab work
In the price
Coaching
In the price
Where each one scores higher
Overall, Ro scores 6.7 and Remedy Meds 5.1 out of 10.
Remedy Meds is stronger on effectiveness (10.0 vs 8.0) and support (7.0 vs 5.5).
Ro is stronger on value (5.0 vs 3.0), user experience (8.0 vs 3.0) and trust & safety (8.0 vs 1.0).
Accessibility is within half a point.
Remedy Meds
5.1/10
Ro
6.7/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Remedy Meds a warning letter dated September 9, 2025 (letter 716830), and it is still open.
Ro has no FDA warning letter on record with us.
Features & Coverage
| Feature | Remedy Meds | Ro |
|---|---|---|
| Starting Price | $299/mo | ✓$149/mo |
| Features | 3 features | ✓7 features |
| States Available | Not disclosed | Not disclosed |
| Compounded | ✓ Yes | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About Remedy Meds
Remedy Meds sells compounded semaglutide and tirzepatide programs through telehealth.
Read our full Remedy Meds review →About Ro
Foundayo (orforglipron), the new oral GLP-1 from Eli Lilly, joined Ro on April 9 2026 at $149/month for the lowest dose, membership on top. Beside it sit compounded semaglutide and the brand-name pair, Zepbound and Wegovy. No obesity care formulary in the category is more comprehensive. In the US, only a handful of direct-to-patient telehealth companies are larger.
Read our full Ro review →Pros & Cons
Remedy Meds
What we like
- The monthly price includes the medication, clinician visits and shipping
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Remedy Meds a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Ro
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits, lab work and coaching
- Names Roman Health Pharmacy LLC as the pharmacy that fills its prescriptions, which most sellers do not
- We found no FDA warning letters issued to Ro
Watch-outs
- Not included in the monthly price: medication
- Confirm it serves your state before you start the intake
Our Verdict
Ro wins this one, 6.7 to 5.1, above all for knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC. It also costs $150 less each month than Remedy Meds.
Choose Remedy Meds if…
You want broader feature coverage and an opening price near $299 a month.
Choose Ro if…
You want knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →RNK Health
An oral route if you will not self-inject
From $197/mo
Get started →He & She MD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →Remedy Meds vs Ro: FAQ
Close alternatives to Remedy Meds and Ro
- Remedy Meds vs Willow
- Remedy Meds vs Apex MD
- Remedy Meds vs Claya
- Remedy Meds vs Elevate Health
- Ro vs Amazon One Medical
- Ro vs LillyDirect Foundayo
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.